News for Vincerx Pharma, Inc. (VINC)

Vincerx Pharma (OTC Pink: VINC) has adjourned its Special Meeting of Stockholders to August 27, 2025, seeking approval for a dissolution proposal. The p

Revised Potential Distribution Range of $0.03 to $0.07 per share

Vincerx Pharma (OTC Pink: VINC) urges stockholders to vote for the dissolution proposal at the upcoming Special Meeting. Potential distribution to stock

Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal

Vincerx Pharma (OTC Pink: VINC) adjourns its Special Meeting of Stockholders to July 16, 2025, to gather sufficient votes for the Dissolution Proposal.

**media[658926]**

U.S. stock futures declined on Monday after a holiday-shortened week that ended with a mixed close on Thursday.

Vincerx Pharma (VINC) has disclosed plans to voluntarily delist its shares from Nasdaq. The company intends to file a Form 25 Notification of Delisting with the

WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the ”œCompany” or ”œWerewolf”) ( HOWL), an innovative biopharmaceutica

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.29% to 37,535.75 whi...

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow tra...

U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following Donald Trump's 104% tariff on China.

SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. ( VINC) today announced that it has entered into a non-binding letter of intent (”

U.S. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark indices rose in premarket trading.

US. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark indices rose in premarket trading.

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. ( VINC) today announced that the previously signed binding Term Sheet between Vincer

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio), a notable investment firm, executed a significant transaction by acquiring an additional 88,55

On December 31, 2024, Prosight Management, LP (Trades, Portfolio) executed a significant transaction involving Vincerx Pharma Inc (VINC), reducing its holdings

Shares of Logility Supply Chain Solutions, Inc. LGTY rose sharply in today's pre-market trading after Aptean announced an agreement to acquire Logility in a $14...